CL
NVO

Choreo LLC’s Novo Nordisk NVO Stock Holding History

Choreo LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.82M Buy
121,486
+14,666
+14% +$630K 0.06% 206
2026
Q1 		$4.05M Sell
106,820
-10,208
-9% -$484K 0.05% 250
2025
Q4 		$5.99M Sell
117,028
-3,208
-3% -$164K 0.08% 178
2025
Q3 		$6.67M Buy
120,236
+1,635
+1% +$95.7K 0.09% 160
2025
Q2 		$8.19M Sell
118,601
-4,427
-4% -$301K 0.11% 126
2025
Q1 		$8.68M Sell
123,028
-4,936
-4% -$408K 0.13% 115
2024
Q4 		$11M Buy
127,964
+79,098
+162% +$8.55M 0.16% 106
2024
Q3 		$5.77M Buy
48,866
+4,128
+9% +$551K 0.08% 168
2024
Q2 		$6.49M Buy
44,738
+41,111
+1,133% +$5.45M 0.11% 126
2024
Q1 		$466K Buy
3,627
+519
+17% +$61.8K 0.01% 441
2023
Q4 		$322K Buy
3,108
+194
+7% +$19.2K 0.01% 478
2023
Q3 		$265K Sell
2,914
-58
-2% -$5.11K 0.01% 388
2023
Q2 		$240K Sell
2,972
-30
-1% -$2.45K 0.01% 414
2023
Q1 		$241K Buy
+3,002
New +$213K 0.01% 426

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Choreo LLC's NVO Position: Q2 2026 in Review

Choreo LLC increased its Novo Nordisk (NVO) stake by 14% in Q2 2026, buying an estimated $630K and bringing the position to 121,486 shares worth $5.82M. The position accounts for 0.06% of the portfolio, ranked #206.

Choreo LLC first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $11M in Q4 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Choreo LLC held 121,486 shares of Novo Nordisk worth $5.82M as of Q2 2026.
  • Choreo LLC bought 14,666 Novo Nordisk shares in Q2 2026, an estimated $630K.
  • Novo Nordisk made up 0.06% of Choreo LLC's portfolio in Q2 2026, its #206 holding.
  • Choreo LLC first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • Choreo LLC's Novo Nordisk position peaked at $11M in Q4 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.